Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
International Immunology|August 8, 2018
Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cellsYukiyoshi Mita, Motoko Y Kimura, Koji Hayashizaki, et al.
Molecular and Cellular Biology|September 2, 2004
Role of F-box protein betaTrcp1 in mammary gland development and tumorigenesisYasusei Kudo, Daniele Guardavaccaro, Patricia G Santamaria, et al.
Plos One|August 23, 2012
Phosphoproteome of human glioblastoma initiating cells reveals novel signaling regulators encoded by the transcriptomeHiroko Kozuka-Hata, Yukiko Nasu-Nishimura, Ryo Koyama-Nasu, et al.
Pathology International|December 17, 2003
Adult-onset familial pulmonary fibrosis in Japanese brothersYasuko Yoshioka, Shigeki Saiki, Yuko Tsutsumi-Ishii, et al.
Thoracic Cancer|October 7, 2021
Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case reportMotoyasu Kato, Mikiko Mori, Keita Miura, et al.
Respiratory Research|December 20, 2019
Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective studyMotoyasu Kato, Tomoko Yamada, Shunichi Kataoka, et al.
International Journal of Molecular Sciences|November 13, 2021
Pannexin 1-Mediated ATP Signaling in the Trigeminal Spinal Subnucleus Caudalis Is Involved in Tongue Cancer PainRyo Koyama, Koichi Iwata, Yoshinori Hayashi, et al.
Scientific Reports|February 2, 2024
Impact of the COVID-19 pandemic on COPD exacerbations in Japanese patients: a retrospective studyToshihiko Nishioki, Tadashi Sato, Akifumi Okajima, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2009
An autopsy case of subacute cor pulmonale due to pulmonary tumor cell emboli in a patient with gastric cancerShin-ichiro Iwakami, Teruhiko Sato, Haruhi Takagi, et al.
Translational Lung Cancer Research|February 11, 2021
Phase I study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring EGFR mutationsRyo Ko, Takehito Shukuya, Chiyo K Imamura, et al.
Pageof 8